# Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion

> **NCT00926952** · PHASE3 · COMPLETED · sponsor: **Innovaderm Research Inc.** · enrollment: 20 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Methylaminolevulinate (Metvix, Metvixia)
- **DEVICE:** Photodynamic Therapy (Aktilite)

## Key facts

- **NCT ID:** NCT00926952
- **Lead sponsor:** Innovaderm Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926952, "Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00926952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*